Kato T, Fujita M, Sawamura Y, Tada M, Abe H, Nagashima K, Nakamura N
Department of Neurosurgery, Hokkaido University School of Medicine.
Noshuyo Byori. 1996 Nov;13(2):99-105.
This report concerns the retrospective immunohistochemical characterization and evaluation of the proliferative potential of eight choroid plexus tumors (CPTs) that included six cases of choroid plexus papilloma (CPP), one of whom had a recurrence, and two cases of choroid plexus carcinoma (CPC). Antibodies to prealbumin, glial fibrillary acidic protein (GFAP), vimentin, keratin, and carcinoembryonic antigen (CEA) were used to determine the immunohistochemical features of interest. The proliferative potential was evaluated with antibodies to proliferating cell nuclear antigen (PCNA) and Ki-67. Antibody binding was visualized by the avidin-biotin-peroxidase complex (ABC) method. Immunoreactivity was scored on a-to 4+ scale, and in the case of PCNA and Ki-67, expected as staining index (SI). All seven CPP specimens were immunostained for prealbumin, but not for CEA. Expression of GFAP, vimentin and keratin varied from one CPP case to another. Both CPCs expressed CEA, but not prealbumin, GFAP and keratin; one of them was vimentin-positive. As determined by immunostaining for Ki-67, the proliferative potential was lower in the CPPs than in the CPCs. Among the former, the highest Ki-67 SI was seen in the primary lesion of a recurring papilloma. On the other hand, immunostaining for PCNA gave less consistent SI values. Our results show that immunohistochemical assays for prealbumin and CEA expression are of significant value for the differential diagnosis of CPPs and CPCs, and that high Ki-67 SI values may serve as an indicator of CPP recurrence, even if the primary lesion is benign.
本报告涉及8例脉络丛肿瘤(CPT)的回顾性免疫组化特征分析及增殖潜能评估,其中包括6例脉络丛乳头状瘤(CPP),1例复发,以及2例脉络丛癌(CPC)。使用抗前白蛋白、胶质纤维酸性蛋白(GFAP)、波形蛋白、角蛋白和癌胚抗原(CEA)的抗体来确定感兴趣的免疫组化特征。用抗增殖细胞核抗原(PCNA)和Ki-67的抗体评估增殖潜能。通过抗生物素蛋白-生物素-过氧化物酶复合物(ABC)法使抗体结合可视化。免疫反应性按1+至4+评分,对于PCNA和Ki-67,以染色指数(SI)表示。所有7例CPP标本均对前白蛋白呈免疫染色,但对CEA不染色。GFAP、波形蛋白和角蛋白的表达在不同的CPP病例中有所不同。2例CPC均表达CEA,但不表达前白蛋白、GFAP和角蛋白;其中1例波形蛋白呈阳性。通过Ki-67免疫染色确定,CPP的增殖潜能低于CPC。在前者中,最高的Ki-67 SI见于1例复发性乳头状瘤的原发灶。另一方面,PCNA免疫染色的SI值不太一致。我们的结果表明,前白蛋白和CEA表达的免疫组化检测对CPP和CPC的鉴别诊断具有重要价值,并且高Ki-67 SI值可能作为CPP复发的指标,即使原发灶是良性的。